Projected Income Statement: Procter & Gamble

Forecast Balance Sheet: Procter & Gamble

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 21,700 24,279 26,361 22,978 24,952 24,289 23,670 23,550
Change - 11.88% 8.58% -12.83% 8.59% -2.66% -2.55% -0.51%
Announcement Date 7/30/21 7/29/22 7/28/23 7/30/24 7/29/25 7/29/26 - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 2,787 3,156 3,062 3,322 3,773 4,233 4,181 4,225
Change - 13.24% -2.98% 8.49% 13.58% 12.19% -1.23% 1.07%
Free Cash Flow (FCF) 1 15,584 13,567 13,786 16,524 14,606 14,939 15,703 16,888
Change - -12.94% 1.61% 19.86% -11.61% 2.28% 5.11% 7.55%
Announcement Date 7/30/21 7/29/22 7/28/23 7/30/24 7/29/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 27.22% 25.71% 25.42% 27.23% 27.65% 27.18% 27.6% 27.78%
EBIT Margin (%) 23.63% 22.21% 22.11% 23.78% 24.27% 23.55% 23.7% 24.02%
EBT Margin (%) 23.14% 22.44% 22.38% 22.32% 23.93% 23.41% 24.22% 24.42%
Net margin (%) 18.79% 18.38% 17.87% 17.7% 18.95% 18.44% 18.95% 19.33%
FCF margin (%) 20.47% 16.92% 16.81% 19.66% 17.33% 17.15% 17.62% 18.29%
FCF / Net Income (%) 108.93% 92.03% 94.08% 111.06% 91.44% 90.89% 92.95% 94.58%

Profitability

        
ROA 11.92% 12.47% 12.31% 13.39% 12.9% 13.03% 13.19% 13.34%
ROE 30.59% 31.53% 31.2% 30.48% 31.06% 30.97% 33.6% 32.47%

Financial Health

        
Leverage (Debt/EBITDA) 1.05x 1.18x 1.26x 1x 1.07x 1.02x 0.96x 0.92x
Debt / Free cash flow 1.39x 1.79x 1.91x 1.39x 1.71x 1.63x 1.51x 1.39x

Capital Intensity

        
CAPEX / Current Assets (%) 3.66% 3.94% 3.73% 3.95% 4.48% 4.86% 4.69% 4.58%
CAPEX / EBITDA (%) 13.45% 15.31% 14.69% 14.52% 16.19% 17.81% 16.99% 16.47%
CAPEX / FCF (%) 17.88% 23.26% 22.21% 20.1% 25.83% 28.33% 26.62% 25.02%

Items per share

        
Cash flow per share 1 7.063 6.586 6.783 8.029 7.259 7.922 8.475 9.146
Change - -6.75% 2.99% 18.37% -9.58% 9.14% 6.97% 7.92%
Dividend per Share 1 3.242 3.523 3.681 3.829 4.076 4.265 4.464 4.663
Change - 8.67% 4.47% 4.02% 6.47% 4.63% 4.67% 4.44%
Book Value Per Share 1 19.2 19.57 19.8 20.45 21.3 23.32 24.49 24.39
Change - 1.93% 1.18% 3.28% 4.15% 9.49% 4.99% -0.41%
EPS 1 5.5 5.81 5.9 6.02 6.51 6.62 7.05 7.47
Change - 5.64% 1.55% 2.03% 8.14% 1.69% 3.86% 5.95%
Nbr of stocks (in thousands) 2,448,233 2,399,297 2,356,969 2,360,135 2,344,542 2,328,599 2,328,599 2,328,599
Announcement Date 7/30/21 7/29/22 7/28/23 7/30/24 7/29/25 7/29/26 - -
1USD
Estimates
2026 2027 *
P/E 22.2x 21.1x
PBR 6.38x 6.08x
EV / Sales 3.92x 4.15x
Yield 2.86% 3%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
148.88USD
Average target price
163.57USD
Spread / Average Target
+9.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PG Stock
  4. PGP Stock
  5. Financials Procter & Gamble